Korsana Biosciences Appoints Mark Vignola, Ph.D., as Chief Financial Officer
WALTHAM, Mass.--(BUSINESS WIRE)--Mar 16, 2026-- Korsana Biosciences, Inc. (“Korsana” or the “Company”), a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced that Mark Vignola …